Citigroup’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $490K | Sell |
134,530
-171,470
| -56% | -$624K | ﹤0.01% | 2945 |
|
|
2025
Q1 | $588K | Buy |
306,000
+69,214
| +29% | +$133K | ﹤0.01% | 2858 |
|
|
2024
Q4 | $450K | Buy |
236,786
+85,381
| +56% | +$162K | ﹤0.01% | 3092 |
|
|
2024
Q3 | $200K | Buy |
151,405
+104,845
| +225% | +$138K | ﹤0.01% | 3579 |
|
|
2024
Q2 | $47.5K | Sell |
46,560
-141,265
| -75% | -$144K | ﹤0.01% | 3882 |
|
|
2024
Q1 | $344K | Sell |
187,825
-117,781
| -39% | -$216K | ﹤0.01% | 3043 |
|
|
2023
Q4 | $379K | Buy |
305,606
+152,869
| +100% | +$190K | ﹤0.01% | 2864 |
|
|
2023
Q3 | $174K | Buy |
152,737
+152,688
| +311,608% | +$174K | ﹤0.01% | 3046 |
|
|
2023
Q2 | $45 | Hold |
49
| – | – | ﹤0.01% | 4713 |
|
|
2023
Q1 | $27 | Sell |
49
-677
| -93% | -$373 | ﹤0.01% | 4622 |
|
|
2022
Q4 | $419 | Sell |
726
-45,897
| -98% | -$26.5K | ﹤0.01% | 4732 |
|
|
2022
Q3 | $15K | Sell |
46,623
-63,664
| -58% | -$20.5K | ﹤0.01% | 4110 |
|
|
2022
Q2 | $39K | Sell |
110,287
-126,503
| -53% | -$44.7K | ﹤0.01% | 3960 |
|
|
2022
Q1 | $170K | Sell |
236,790
-439,396
| -65% | -$315K | ﹤0.01% | 3484 |
|
|
2021
Q4 | $1.53M | Buy |
676,186
+227,543
| +51% | +$514K | ﹤0.01% | 2174 |
|
|
2021
Q3 | $1.29M | Sell |
448,643
-464,125
| -51% | -$1.34M | ﹤0.01% | 2214 |
|
|
2021
Q2 | $3.46M | Sell |
912,768
-221,780
| -20% | -$840K | ﹤0.01% | 1711 |
|
|
2021
Q1 | $3.84M | Buy |
1,134,548
+1,090,721
| +2,489% | +$3.69M | ﹤0.01% | 1507 |
|
|
2020
Q4 | $123K | Buy |
43,827
+28,335
| +183% | +$79.5K | ﹤0.01% | 3546 |
|
|
2020
Q3 | $39K | Sell |
15,492
-592,605
| -97% | -$1.49M | ﹤0.01% | 3603 |
|
|
2020
Q2 | $8.26M | Buy |
608,097
+509,968
| +520% | +$6.93M | 0.01% | 862 |
|
|
2020
Q1 | $744K | Buy |
98,129
+30,762
| +46% | +$233K | ﹤0.01% | 2016 |
|
|
2019
Q4 | $425K | Sell |
67,367
-256,337
| -79% | -$1.62M | ﹤0.01% | 2733 |
|
|
2019
Q3 | $1.27M | Sell |
323,704
-17,508
| -5% | -$68.6K | ﹤0.01% | 1941 |
|
|
2019
Q2 | $1.65M | Buy |
341,212
+302,319
| +777% | +$1.46M | ﹤0.01% | 1784 |
|
|
2019
Q1 | $318K | Sell |
38,893
-258,612
| -87% | -$2.11M | ﹤0.01% | 2813 |
|
|
2018
Q4 | $1.65M | Buy |
297,505
+245,988
| +477% | +$1.36M | ﹤0.01% | 1653 |
|
|
2018
Q3 | $455K | Buy |
51,517
+7,052
| +16% | +$62.3K | ﹤0.01% | 2607 |
|
|
2018
Q2 | $444K | Buy |
44,465
+8,606
| +24% | +$85.9K | ﹤0.01% | 2438 |
|
|
2018
Q1 | $342K | Sell |
35,859
-6,413
| -15% | -$61.2K | ﹤0.01% | 2555 |
|
|
2017
Q4 | $629K | Buy |
42,272
+14,971
| +55% | +$223K | ﹤0.01% | 2216 |
|
|
2017
Q3 | $537K | Buy |
27,301
+23,321
| +586% | +$459K | ﹤0.01% | 2373 |
|
|
2017
Q2 | $57K | Buy |
3,980
+3,658
| +1,136% | +$52.4K | ﹤0.01% | 3527 |
|
|
2017
Q1 | $3K | Sell |
322
-8,744
| -96% | -$81.5K | ﹤0.01% | 4564 |
|
|
2016
Q4 | $94K | Buy |
9,066
+9,041
| +36,164% | +$93.7K | ﹤0.01% | 3931 |
|
|
2016
Q3 | $0 | Sell |
25
-8,094
| -100% | – | ﹤0.01% | 4878 |
|
|
2016
Q2 | $61K | Sell |
8,119
-14,991
| -65% | -$113K | ﹤0.01% | 3593 |
|
|
2016
Q1 | $208K | Buy |
23,110
+13,758
| +147% | +$124K | ﹤0.01% | 3442 |
|
|
2015
Q4 | $121K | Buy |
9,352
+8,642
| +1,217% | +$112K | ﹤0.01% | 3447 |
|
|
2015
Q3 | $7K | Sell |
710
-3,330
| -82% | -$32.8K | ﹤0.01% | 4517 |
|
|
2015
Q2 | $42K | Buy |
4,040
+940
| +30% | +$9.77K | ﹤0.01% | 3840 |
|
|
2015
Q1 | $34K | Sell |
3,100
-2,516
| -45% | -$27.6K | ﹤0.01% | 4090 |
|
|
2014
Q4 | $65K | Buy |
5,616
+5,334
| +1,891% | +$61.7K | ﹤0.01% | 3920 |
|
|
2014
Q3 | $6K | Buy |
282
+176
| +166% | +$3.75K | ﹤0.01% | 4825 |
|
|
2014
Q2 | $3K | Buy |
+106
| New | +$3K | ﹤0.01% | 4969 |
|